Trial Profile
Loteprednol etabonate/tobramycin vs tobramycin/dexamethasone in Chinese patients with ocular inflammation associated with blepharokeratoconjunctivitis.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 24 Apr 2013
Price :
$35
*
At a glance
- Drugs Loteprednol etabonate/tobramycin (Primary) ; Tobramycin/dexamethasone
- Indications Bacterial infections; Blepharoconjunctivitis; Keratoconjunctivitis
- Focus Therapeutic Use
- Sponsors Bausch & Lomb
- 27 Feb 2012 New source identified and integrated (NCT01028027; ClinicalTrials.gov: US National Institutes of Health).
- 03 Feb 2012 New trial record
- 19 Jan 2012 Results published in Current Medical Research and Opinion.